Corrigendum to “Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway” [Biochem. Biophys. Res. Commun. 510 (2019) 20–26]

Zhi Li(Dalian Medical University), Huimin Du(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jianping Gong(University of Electronic Science and Technology of China), Zhibo Zhao, Wei Zhu(Ministry of Education of the People's Republic of China), Panpan Feng(Qilu Hospital of Shandong University)
Biochemical and Biophysical Research Communications
January 23, 2020
10.1016/j.bbrc.2020.01.049
Cited by 1

Related Papers

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
|Annals of the Rheumatic Diseases|2011|412
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
|PLoS ONE|2012|196
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
|Annals of the Rheumatic Diseases|2013|168
A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth
|Oncogene|2011|135
A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4<sup>+</sup>T cell receptor repertoire clonality
|OncoImmunology|2015|113